Synthetic Opioids Market Growth, Analysis, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Synthetic Opioids Market covers analysis by Product Type (Synthetic Opioids, Semi Synthetic Opioids); Application (Pain Management, De-Addiction); Distribution Channel (Retail Outlets, Hospitals), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00012162
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

The Synthetic Opioids Market is expected to register a CAGR of 1.6% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.

The research report on the Synthetic Opioids Market is segmented by product into synthetic and semi synthetic opioids. Applications analyzed include pain management, anesthesia, addiction treatment, and cancer-related pain. Distribution channels include retail outlets, and hospitals. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses. This report explores the growing use of synthetic opioids for pain relief, the challenges related to opioid misuse and addiction, and the regulatory landscape influencing market growth.

Purpose of the Report

The report Synthetic Opioids Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Synthetic Opioids Market Segmentation

Product Type

  • Synthetic Opioids
  • Semi Synthetic Opioids

Application

  • Pain Management
  • De-Addiction

Distribution Channel

  • Retail Outlets
  • Hospitals

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Synthetic Opioids Market: Strategic Insights

synthetic-opioids-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Synthetic Opioids Market Growth Drivers

  • Increasing Incidence of Chronic Pain Disorders:
    The synthetic opioids market is highly driven by the increasingly high prevalence of chronic pain disorders like arthritis, back pain, and cancer. Pain due to these chronic disorders often requires long-term pain management and results in the use of opioids as prescription medication. As people grow older and the incidence of chronic pain increases, the prescribing of potent painkillers, such as synthetic opioids, is also likely to increase further. Synthetic opioids, such as fentanyl and its analogs, are highly effective for managing severe pain, making them a go-to option for healthcare providers. The market is expanding as healthcare professionals increasingly rely on these medications to help improve the quality of life for patients living with chronic pain.
  • Growing Demand for Fast-Acting Pain Relief: Synthetic opioids favor the medical arena, since they are fast-acting especially in severe pain. Patients who are due for immediate pain relief say those who have just undergone surgery or experienced trauma would go quickly with synthetic opioids. Their fast action led to their comprehensive application in the hospitals and emergency wards. As the demand for pain management drugs is increasing in a rapid manner, the need for synthetic opioids such as fentanyl, hydromorphone, and oxycodone is bound to increase with market growth.
  • Rise in the Use of Opioid Analgesics for Acute and Postoperative Pain:
    In the post-operative phase, there is a massive pain that develops, which the patient needs urgent relief from. Synthetic opioids are often prescribed to patients during the acute pain period after surgery. These drugs help manage severe pain and prevent the development of chronic pain conditions. As surgical procedures continue to increase worldwide due to advancements in medical treatments, the need for post-surgical pain management through opioids will likely remain high, driving the demand for synthetic opioids. Furthermore, their use in palliative care for patients with terminal conditions contributes to market growth.

Synthetic Opioids Market Future Trends

  • Rising Concerns over opioid abuse and addiction: Although synthetic opioids are very effective in pain management, abuse potential and high addiction have become bigger concerns with their use. The ongoing opioid crisis in many parts of the world, especially in the U.S., has put the focus on drug misuse. As a result, healthcare providers are becoming more conservative in their prescribing practices, resulting in a move toward increased regulation and monitoring of synthetic opioid use. This movement is driving the creation of ADFs to prevent misuse. These formulations should reduce the chances of addiction and overdose while remaining effective for pain relief in the patient who requires it.
  • Development of Abuse-Deterrent Formulations (ADFs):
    To address the burgeoning issues associated with opioid abuse, pharmaceutical companies have been investing in the development of abuse-deterrent formulations, or ADFs, of synthetic opioids. These formulations deter the user from misusing the drug through structural changes to the pill's chemistry or through addition of physical barriers that cannot be tampered with. For example, tamper-resistant formulations make it harder for the abuser to crush or dissolve them before snorting the drug, significantly reducing the risks of abuse. As part of a broader effort to curb opioid misuse, the development and approval of ADFs are expected to become a key trend, helping to mitigate the negative societal impacts of synthetic opioid use while maintaining their therapeutic benefits.
  • Shift Toward Alternative Pain Management Solutions:
    Another significant trend in the synthetic opioids market is the growing interest in alternative pain management therapies. While synthetic opioids remain highly effective for severe pain, there is increasing research into non-opioid alternatives for pain relief. These alternatives include non-steroidal anti-inflammatory drugs (NSAIDs), nerve-blocking treatments, physical therapy, and even newer approaches like cannabinoid-based therapies. There is an increase in the usage of opioids combined with other non-opioid pain management strategies in an attempt by the medical community to reduce reliance on opioids. This, therefore, presents an impact to be expected for the future growth of the synthetic opioid market.

Synthetic Opioids Market Opportunities

  • Innovations in Synthetic Non-Addictive Opioids:
    There exists huge opportunity in that pharmaceutical firms design synthetic opioids from which they acquire pain relief similar to natural opioid but is without the addiction-potential counterpart. Investigate non-addictive synthetic opioid is very promising, and one of these who will develop non-addictive synthetic drugs opens a tremendous channel for business operations. These products would address issues of opioid abuse but still manage pain effectively for patients. Their development would thus be a big opportunity for pharmaceutical companies to establish a competitive advantage, especially in the wake of growing global attention on opioid abuse.
  • Growing Demand for Personalized Pain Management: Personalized medicine, which delivers treatments based on individual genetic and phenotypic profiles, offers an opportunity in the synthetic opioids market. Personalized pain management allows for more precise prescriptions of opioids, ensuring that patients receive the appropriate dosage and type of opioid, reducing the risk of misuse and overdose. The use of genetic testing to determine how an individual metabolizes opioids can improve treatment outcomes and reduce the chances of addiction. This trend offers new avenues for synthetic opioid developers to launch customized pain management solutions, thereby enabling safer and more efficient pain relief methods.
  • Collaborations and Strategic Partnerships: Pharmaceutical companies, healthcare organizations, and government agencies can collaborate to combat the opioid crisis through research and development and education. Collaboration will enable stakeholders to develop a solution that balances the need for pain relief and the necessity of reducing further abuse of opioids. Partnerships may lead to the development of safer opioid alternatives, the introduction of abuse-deterrent formulations, and more robust systems for tracking opioid prescriptions. Such partnerships may expand market reach and assure responsible use of synthetic opioids, which could help open the door for continued growth in the market.

Synthetic Opioids Market Regional Insights

The regional trends and factors influencing the Synthetic Opioids Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Synthetic Opioids Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Synthetic Opioids Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 1.6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product Type
  • Synthetic Opioids
  • Semi Synthetic Opioids
By Application
  • Pain Management
  • De-Addiction
By Distribution Channel
  • Retail Outlets
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Adamis Pharmaceuticals Corporation
  • Endo International plc
  • Impax Laboratories, Inc.
  • Indivior Plc.
  • Janssen Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals plc
  • Mylan N.V.
  • Pfizer Inc.
  • Purdue Pharma LP

  • Synthetic Opioids Market Players Density: Understanding Its Impact on Business Dynamics

    The Synthetic Opioids Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    synthetic-opioids-market-cagr

    • Get the Synthetic Opioids Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Synthetic Opioids Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Synthetic Opioids Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What is the expected CAGR of the Synthetic Opioids Market?
    The Synthetic Opioids Market is expected to register a CAGR of 1.6% from 2025-2031.
    2
    What are the driving factors impacting the Synthetic Opioids Market?
    The major driving factors supporting the Synthetic Opioids Market growth are- Increasing Incidence of Chronic Pain Disorders, Growing Demand for Fast-Acting Pain Relief,and Rise in the Use of Opioid Analgesics for Acute and Postoperative Pain
    3
    What are the future trends in the Synthetic Opioids Market?
    Key Future Trends in the Synthetic Opioids Market are- Rising Concerns over opioid abuse and addiction, Development of Abuse-Deterrent Formulations (ADFs), and Shift Toward Alternative Pain Management Solutions
    4
    Which are the key players in the Synthetic Opioids Market?
    Key companies in Synthetic Opioids Market are - Adamis Pharmaceuticals Corporation, Endo International plc, Impax Laboratories, Inc., Indivior Plc., Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals plc, Mylan N.V., Pfizer Inc., Purdue Pharma LP
    5
    What are the deliverable formats of the Synthetic Opioids Market?
    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
    6
    What are the options available for the customization of this report?
    Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can't access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Adamis Pharmaceuticals Corporation
    2. Endo International plc.
    3. Impax Laboratories, Inc.
    4. Indivior Plc.
    5. Janssen Pharmaceuticals, Inc.
    6. Mallinckrodt Pharmaceuticals plc
    7. Mylan N.V.
    8. Pfizer Inc.
    9. Purdue Pharma LP,
    10. Teva Pharmaceuticals
    11. West-Ward Pharmaceuticals (Hikma's US subsidiary)
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo